Sulfonylureas, Basal Insulins Tied to Increased CV Risk in T2D (CME/CE)

(MedPage Today) -- Newer agents and TZDs appear safer than older drugs in second-line for CV health
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news